A. Schuster

发表

Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

C. Frost, Jessie Wang, S. Nepal, 2012, British journal of clinical pharmacology.

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects.

A. Shenker, C. Frost, Jessie Wang, 2013, British journal of clinical pharmacology.

Effects of Age, Gender and Diurnal Variation on the Steady‐State Pharmacokinetics (PK) of BMS‐181101

A. Schuster, N. Srinivas, W. Shyu, 1996 .

Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban

A. Shenker, C. Frost, Jessie Wang, 2015, Clinical Pharmacokinetics.

The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects

C. Frost, Jessie Wang, A. Schuster, 2017, Clinical pharmacology : advances and applications.

LC-MS/MS determination of apixaban (BMS-562247) and its major metabolite in human plasma: an application of polarity switching and monolithic HPLC column.

Jim X. Shen, A. Schuster, Oanh T Dang, 2014, Bioanalysis.

Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects

C. Frost, Jessie Wang, A. Schuster, 2013, Clinical pharmacology : advances and applications.

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor.

A. Shenker, C. Frost, Jessie Wang, 2015, British journal of clinical pharmacology.

Quantitative determination of the HIV protease inhibitor atazanavir (BMS-232632) in human plasma by liquid chromatography-tandem mass spectrometry following automated solid-phase extraction.

A. Schuster, M. Jemal, M Jemal, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.

Mohammed Jemal, A. Schuster, M. Jemal, 2003, Rapid communications in mass spectrometry : RCM.

Manual and automated determination of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and its metabolite (E)-5-(2-bromovinyl)uracil in urine.

A. Schuster, D. Whigan, 1995, Journal of chromatography. B, Biomedical applications.

High-performance liquid chromatographic-electrochemical assay for the quantitation of BMS-181885 in monkey plasma.

A. Schuster, N. Srinivas, W. Shyu, 1998, Journal of chromatography. B, Biomedical sciences and applications.

Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation.

A. Schuster, M. Jemal, D. Whigan, 2000, Rapid communications in mass spectrometry : RCM.

Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects

A. Shenker, C. Frost, S. Nepal, 2018, Journal of clinical pharmacology.

Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans

W. Humphreys, K. He, R. Knabb, 2009, Drug Metabolism and Disposition.

Application of a design of experiment approach in the development of a sensitive bioanalytical assay in human plasma.

A. Schuster, A. Aubry, J. Bergum, 2012, Journal of pharmaceutical and biomedical analysis.

Dried blood spot analysis without dilution: Application to the LC-MS/MS determination of BMS-986001 in rat dried blood spot.

Jim X. Shen, A. Schuster, Long Yuan, 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Formulation of Solid Dosage Forms to Overcome Gastric pH Interaction of the Factor Xa Inhibitor, BMS-561389

S. Badawy, F. Zhao, M. Hussain, 2006, Pharmaceutical Research.

Effects of age, gender, and diurnal variation on the steady‐state pharmacokinetics of BMS‐181101, an antidepressant, in healthy subjects

A. Schuster, N. Srinivas, C. Gleason, 1997, Clinical pharmacology and therapeutics.

Development of a validated liquid chromatography tandem mass spectrometry assay for a PEGylated adnectin in cynomolgus monkey plasma using protein precipitation and trypsin digestion.

A. Schuster, Jonathan Haulenbeek, Jian Wang, 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Comparative Metabolism of 14 C-Labeled Apixaban in Mice , Rats , Rabbits , Dogs , and Humans

W. Humphreys, K. He, R. Knabb, 2009 .

COMPARATIVE METABOLISM OF C-14-LABELED APIXABAN IN MICE, RATS, RABBITS, DOGS, AND HUMANS

K. He, R. Knabb, A. Schuster, 2009 .

Clinical Pharmacology: Advances and Applications The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects

C. Frost, Jessie Wang, A. Schuster, 2022 .

A preliminary pharmacokinetic and pharmacodynamic evaluation of the HIV protease inhibitor BMS-232632 in a protease inhibitor-naive HIV+ population

G. Drusano, A. Schuster, P. Piliero, 2000 .